Amarin reported $126.83M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 13.82B 1.34B Jun/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
Amarin USD 126.83M 477K Dec/2025
AstraZeneca USD 18.87B 11M Sep/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
DBV Technologies USD 17.5M 2.4M Sep/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
Halozyme Therapeutics USD 518.59M 65.26M Sep/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 88M 29.15M Sep/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 957.3M 70.3M Sep/2026
Novartis USD 9.96B 109M Sep/2026